Skip to main content

Publications

  1. Castellani RJ, Jamshidi P  Cerebral amyloid-β-related angiitis and iatrogenic cerebral amyloid angiopathy-related vasculitis: Implications for amyloid-related imaging abnormalities.  J Neuropathol Exp Neurol  2024 Jul 05;. pii:nlae068
  2. Kostelecky N, Wadhwani N, Golubovich I, Vormittag-Nocito E, Gao J, Jennings L, Caron M, Jamshidi P, Ahrendsen JT, Castellani R  et al.  Transdifferentiation of metastatic melanoma into cerebellar angiosarcoma.  J Neuropathol Exp Neurol  2024 Jul 04;. pii:nlae075
  3. Chia R, Ray A, Shah Z, Ding J, Ruffo P, Fujita M, Menon V, Saez-Atienzar S, Reho P, Kaivola K  et al.  Genome sequence analyses identify novel risk loci for multiple system atrophy.  Neuron  2024 Jul 03;112(13):2142-2156.e5. doi:10.1016/j.neuron.2024.04.002
  4. Nassan M  Proposal for a Mechanistic Disease Conceptualization in Clinical Neurosciences: The Neural Network Components (NNC) Model.  Harv Rev Psychiatry  2024 Jul 01;32(4):150-159. doi:10.1097/HRP.0000000000000399
  5. Cahan J, Finley JA, Cotton E, Orban ZS, Jimenez M, Weintraub S, Sorets T, Koralnik IJ  Cognitive functioning in patients with neuro-PASC: the role of fatigue, mood, and hospitalization status.  Front Neurol  2024;15:1401796. pii:1401796
  6. Russo ML, Ayala G, Neal D, Rogalsky AE, Ahmad S, Musial TF, Pearlman M, Bean LA, Farooqi AK, Ahmed A  et al.  Alzheimer's-linked axonal changes accompany elevated antidromic action potential failure rate in aged mice.  Brain Res  2024 Jun 10;1841:149083. doi:10.1016/j.brainres.2024.149083
  7. McCord M, Jamshidi P  Targeting the cell cycle to enhance chemotherapy efficacy in glioblastoma.  Neuro Oncol  2024 Jun 03;26(6):1097-1098. doi:10.1093/neuonc/noae062
  8. Høilund-Carlsen PF, Alavi A, Barrio JR, Castellani RJ, Costa T, Herrup K, Kepp KP, Neve RL, Perry G, Revheim ME  et al.  Donanemab, another anti-Alzheimer's drug with risk and uncertain benefit.  Ageing Res Rev  2024 Jun 01;99:102348. doi:10.1016/j.arr.2024.102348
  9. Valentino RR, Scotton WJ, Roemer SF, Lashley T, Heckman MG, Shoai M, Martinez-Carrasco A, Tamvaka N, Walton RL, Baker MC  et al.  MAPT H2 haplotype and risk of Pick's disease in the Pick's disease International Consortium: a genetic association study.  Lancet Neurol  2024 May;23(5):487-499. doi:10.1016/S1474-4422(24)00083-8
  10. Ayala I, Bahrami A, Pan Y, Spencer C, Flanagan ME, Mesulam MM, Gefen T, Geula C  Loss and microglia phagocytosis of synaptic proteins in frontotemporal lobar degeneration with TDP-43 proteinopathy.  Neurochem Int  2024 May;175:105719. doi:10.1016/j.neuint.2024.105719
  11. Vandebergh M, Ramos EM, Corriveau-Lecavalier N, Ramanan VK, Kornak J, Mester C, Kolander T, Brushaber D, Staffaroni AM, Geschwind D  et al.  Gene specific effects on brain volume and cognition of TMEM106B in frontotemporal lobar degeneration.  medRxiv  2024 Apr 05;. pii:2024.04.05.24305253
  12. Iverson GL, Gardner AJ, Castellani RJ, Kissinger-Knox A  Applying the Consensus Criteria for Traumatic Encephalopathy Syndrome Retrospectively to Case Studies of Boxers from the 20th Century.  Neurotrauma Rep  2024;5(1):337-347. doi:10.1089/neur.2023.0134
  13. Høilund-Carlsen PF, Alavi A, Castellani RJ, Neve RL, Perry G, Revheim ME, Barrio JR  Alzheimer's Amyloid Hypothesis and Antibody Therapy: Melting Glaciers?  Int J Mol Sci  2024 Mar 31;25(7). pii:3892
  14. Turner M, Belli A, Castellani RJ  Changes in Brain Structure and Function in a Multisport Cohort of Retired Female and Male Athletes, Many Years after Suffering a Concussion: Implications for Neuroplasticity and Neurodegenerative Disease Pathogenesis.  J Alzheimers Dis Rep  2024;8(1):501-516. doi:10.3233/ADR-240021
  15. Kawles A, Keszycki R, Minogue G, Zouridakis A, Ayala I, Gill N, Macomber A, Lubbat V, Coventry C, Rogalski E  et al.  Phenotypically concordant distribution of pick bodies in aphasic versus behavioral dementias.  Acta Neuropathol Commun  2024 Feb 22;12(1):31. pii:31
  16. Tyner CE, Boulton AJ, Slotkin J, Cohen ML, Weintraub S, Gershon RC, Tulsky DS  Exploring symptom clusters in mild cognitive impairment and dementia with the NIH Toolbox.  J Int Neuropsychol Soc  2024 Feb 16;:1-12. doi:10.1017/S1355617724000055
  17. Walenski M, Sostarics T, Mesulam MM, Thompson CK  The production of adjectives in narratives by individuals with primary progressive aphasia.  J Neurolinguistics  2024 Feb;69. pii:101179
  18. Paudel B, Jeong SY, Martinez CP, Rickman A, Haluck-Kangas A, Bartom ET, Fredriksen K, Affaneh A, Kessler JA, Mazzulli JR  et al.  Death Induced by Survival gene Elimination (DISE) correlates with neurotoxicity in Alzheimer's disease and aging.  Nat Commun  2024 Jan 18;15(1):264. pii:264
  19. Mather MA, Ho EH, Bedjeti K, Karpouzian-Rogers T, Rogalski EJ, Gershon R, Weintraub S  Measuring Multidimensional Aspects of Health in the Oldest Old Using the NIH Toolbox: Results From the ARMADA Study.  Arch Clin Neuropsychol  2024 Jan 12;. pii:acad105
  20. Høilund-Carlsen PF, Alavi A, Barrio JR, Castellani RJ, Costa T, Herrup K, Kepp KP, Neve RL, Perry G, Revheim ME  et al.  Revision of Alzheimer's diagnostic criteria or relocation of the Potemkin village.  Ageing Res Rev  2024 Jan;93:102173. doi:10.1016/j.arr.2023.102173
  21. Echevarria-Cooper SL, Ho EH, Gershon RC, Weintraub S, Kahnt T  Evaluation of the NIH Toolbox Odor Identification Test across normal cognition, amnestic mild cognitive impairment, and dementia due to Alzheimer's disease.  Alzheimers Dement  2024 Jan;20(1):288-300. doi:10.1002/alz.13426
  22. Reznicek J, Sharifai N, Jamshidi P, Wadhwani N, Ahrendsen JT  Embryonal and pineal tumours.  Cytopathology  2023 Dec 15;. doi:10.1111/cyt.13350
  23. Petersen RC, Weintraub S, Sabbagh M, Karlawish J, Adler CH, Dilworth-Anderson P, Frank L, Huling Hummel C, Taylor A,   A New Framework for Dementia Nomenclature.  JAMA Neurol  2023 Dec 01;80(12):1364-1370. doi:10.1001/jamaneurol.2023.3664
  24. Minogue G, Kawles A, Zouridakis A, Keszycki R, Macomber A, Lubbat V, Gill N, Mao Q, Flanagan ME, Zhang H  et al.  Distinct Patterns of Hippocampal Pathology in Alzheimer's Disease with Transactive Response DNA-binding Protein 43.  Ann Neurol  2023 Dec;94(6):1036-1047. doi:10.1002/ana.26762
  25. Zouridakis A, Ayala I, Minogue G, Kawles A, Keszycki R, Macomber A, Bigio EH, Geula C, Mesulam MM, Gefen T  Shades of gray in human white matter.  J Comp Neurol  2023 Dec;531(18):2109-2120. doi:10.1002/cne.25512
  26. Franzen S, Nuytemans K, Bourdage R, Caramelli P, Ellajosyula R, Finger E, Illán-Gala I, Loi SM, Morhardt D, Pijnenburg Y  et al.  Gaps in clinical research in frontotemporal dementia: A call for diversity and disparities-focused research.  Alzheimers Dement  2023 Dec;19(12):5817-5836. doi:10.1002/alz.13129
  27. McCord M, Jamshidi P, Thirunavu V, Santana-Santos L, Vormittag-Nocito E, Dittman D, Parker S, Baczkowski J, Jennings L, Walshon J  et al.  Variant allelic frequencies of driver mutations can identify gliomas with potentially false-negative MGMT promoter methylation results.  Acta Neuropathol Commun  2023 Nov 02;11(1):175. pii:175
  28. Lapins A, Bonakdarpour B  The case of a 60-year-old man with decline in job performance and changes in personality and judgment.  Ann Clin Transl Neurol  2023 Nov;10(11):2171-2172. doi:10.1002/acn3.51917
  29. Engelmeyer JR, Kerr A, Makowski-Woidan BA, Gill NP, Mesulam MM, Weintraub S, Zhang H, Lindquist L, Rogalski EJ  Medical characterization of cognitive SuperAgers: Investigating the medication profile of SuperAgers.  J Am Geriatr Soc  2023 Nov;71(11):3638-3641. doi:10.1111/jgs.18496
  30. Hammers DB, Nemes S, Diedrich T, Eloyan A, Kirby K, Aisen P, Kramer J, Nudelman K, Foroud T, Rumbaugh M  et al.  Learning slopes in early-onset Alzheimer's disease.  Alzheimers Dement  2023 Nov;19 Suppl 9(Suppl 9):S19-S28. doi:10.1002/alz.13159
  31. Zhang M, Ho E, Nowinski CJ, Fox RS, Ayturk E, Karpouzian-Rogers T, Novack M, Dodge HH, Weintraub S, Gershon R  The Paradox in Positive and Negative Aspects of Emotional Functioning Among Older Adults with Early Stages of Cognitive Impairment.  J Aging Health  2023 Oct 06;:8982643231199806. doi:10.1177/08982643231199806
  32. Pang L, Dunterman M, Guo S, Khan F, Liu Y, Taefi E, Bahrami A, Geula C, Hsu WH, Horbinski C  et al.  Kunitz-type protease inhibitor TFPI2 remodels stemness and immunosuppressive tumor microenvironment in glioblastoma.  Nat Immunol  2023 Oct;24(10):1654-1670. doi:10.1038/s41590-023-01605-y
  33. Gasca-Salas C, Duff-Canning S, McArthur E, Armstrong MJ, Fox S, Meaney CA, Tang-Wai DF, Gill D, Eslinger PJ, Zadikoff C  et al.  Predictors of Cognitive Change in Parkinson Disease: A 2-year Follow-up Study.  Alzheimer Dis Assoc Disord  ;37(4):335-342. doi:10.1097/WAD.0000000000000576
  34. Zhang L, Flagan TM, Häkkinen S, Chu SA, Brown JA, Lee AJ, Pasquini L, Mandelli ML, Gorno-Tempini ML, Sturm VE  et al.  Network Connectivity Alterations across the MAPT Mutation Clinical Spectrum.  Ann Neurol  2023 Oct;94(4):632-646. doi:10.1002/ana.26738
  35. Upadhyay A, Chhangani D, Rao NR, Kofler J, Vassar R, Rincon-Limas DE, Savas JN  Amyloid fibril proteomics of AD brains reveals modifiers of aggregation and toxicity.  Mol Neurodegener  2023 Sep 14;18(1):61. pii:61
  36. Bonakdarpour B, Zhou G, Huang D, Vidano CT, Schuele S, Zelano C, Takarabe C  Calming effect of Clinically Designed Improvisatory Music for patients admitted to the epilepsy monitoring unit during the COVID-19 pandemic: a pilot study.  Front Neurol  2023;14:1206171. pii:1206171
  37. Celis K, Moreno MDMM, Rajabli F, Whitehead P, Hamilton-Nelson K, Dykxhoorn DM, Nuytemans K, Wang L, Flanagan M, Weintraub S  et al.  Ancestry-related differences in chromatin accessibility and gene expression of APOE ε4 are associated with Alzheimer's disease risk.  Alzheimers Dement  2023 Sep;19(9):3902-3915. doi:10.1002/alz.13075
  38. Nassan M, Daghlas I, Piras IS, Rogalski E, Reus LM, Pijnenburg Y, Cuddy LK, Saxena R, Mesulam MM, Huentelman M  Evaluating the association between genetically proxied ACE inhibition and dementias.  Alzheimers Dement  2023 Sep;19(9):3894-3901. doi:10.1002/alz.13062
  39. Wiseman K, Slotkin J, Spratford M, Haggerty A, Heusinkvelt M, Weintraub S, Gershon R, McCreery R  Validation of a tablet-based assessment of auditory sensitivity for researchers.  Behav Res Methods  2023 Sep;55(6):2838-2852. doi:10.3758/s13428-022-01933-1
  40. Mao C, Xu J, Rasmussen L, Li Y, Adekkanattu P, Pacheco J, Bonakdarpour B, Vassar R, Shen L, Jiang G  et al.  AD-BERT: Using pre-trained language model to predict the progression from mild cognitive impairment to Alzheimer's disease.  J Biomed Inform  2023 Aug;144:104442. doi:10.1016/j.jbi.2023.104442
  41. Iverson GL, Kissinger-Knox A, Huebschmann NA, Castellani RJ, Gardner AJ  A narrative review of psychiatric features of traumatic encephalopathy syndrome as conceptualized in the 20th century.  Front Neurol  2023;14:1214814. pii:1214814
  42. Sadleir KR, Vassar R  Connections between ApoE, sleep, and Aβ and tau pathologies in Alzheimer's disease.  J Clin Invest  2023 Jul 17;133(14). pii:e171838
  43. Castellani RJ, Perry G  The Teflon hypothesis.  Brain Commun  2023;5(4):fcad203. pii:fcad203
  44. Chandra S, Di Meco A, Dodiya HB, Popovic J, Cuddy LK, Weigle IQ, Zhang X, Sadleir K, Sisodia SS, Vassar R  The gut microbiome regulates astrocyte reaction to Aβ amyloidosis through microglial dependent and independent mechanisms.  Mol Neurodegener  2023 Jul 06;18(1):45. pii:45
  45. Høilund-Carlsen PF, Revheim ME, Costa T, Kepp KP, Castellani RJ, Perry G, Alavi A, Barrio JR  FDG-PET versus Amyloid-PET Imaging for Diagnosis and Response Evaluation in Alzheimer's Disease: Benefits and Pitfalls.  Diagnostics (Basel)  2023 Jul 03;13(13). pii:2254
  46. Mesulam MM, Gefen T, Flanagan M, Castellani R, Jamshidi P, Barbieri E, Sridhar J, Kawles A, Weintraub S, Geula C  et al.  Frontotemporal Degeneration with Transactive Response DNA-Binding Protein Type C at the Anterior Temporal Lobe.  Ann Neurol  2023 Jul;94(1):1-12. doi:10.1002/ana.26677
  47. Toller G, Cobigo Y, Callahan P, Appleby BS, Brushaber D, Domoto-Reilly K, Forsberg LK, Ghoshal N, Graff-Radford J, Graff-Radford NR  et al.  Multisite ALLFTD study modeling progressive empathy loss from the earliest stages of behavioral variant frontotemporal dementia.  Alzheimers Dement  2023 Jul;19(7):2842-2852. doi:10.1002/alz.12898
  48. Cahan JG, Vassar R, Bonakdarpour B  Lower Cerebrospinal Fluid Amyloid-β42 Predicts Sooner Time to Antipsychotic Use in Alzheimer's Disease.  J Alzheimers Dis Rep  2023;7(1):641-647. doi:10.3233/ADR-220064
  49. Iverson GL, Jamshidi P, Fisher-Hubbard AO, Deep-Soboslay A, Hyde TM, Kleinman JE, deJong JL, Shepherd CE, Hazrati LN, Castellani RJ  Chronic traumatic encephalopathy neuropathologic change is uncommon in men who played amateur American football.  Front Neurol  2023;14:1143882. pii:1143882
  50. Keszycki R, Kawles A, Minogue G, Zouridakis A, Macomber A, Gill N, Vu M, Zhang H, Coventry C, Rogalski E  et al.  Distinct and shared neuropsychiatric phenotypes in FTLD-tauopathies.  Front Aging Neurosci  2023;15:1164581. pii:1164581

Follow Mesulam Center on Facebook